Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...

Biotechnology companies are developing novel obesity medicines to compete with blockbuster weight-loss drugs.

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

However, they estimate that if that amount had been spent on NHS services that could not be funded due to the allocation of resources to new drugs, an estimated 5 million additional QALYs could ...